Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy ResearchNOW IN
    Article

    Antifungal Activity of Hydroalcoholic Extract of Chrysobalanus icaco Against Oral Clinical Isolates of Candida Species

    João Paulo Bastos Silva1, Ana Regina Maués Noronha Peres1, Thiago Portal Paixão1, Andressa Santa Brígida Silva2, Ana Cristina Baetas1, Wagner Luiz Ramos Barbosa3, Marta Chagas Monteiro1, Marcieni Ataíde Andrade1★★ Corresponding author

    1. 1Graduate Program in Pharmaceutical Sciences, Institute of Health Sciences, Federal University of Pará, Belém, Pará, BRAZIL.
    2. 2Pharmaceutical Innovation Graduate Program, Institute of Health Sciences, Federal University of Pará, Belém, Pará, BRAZIL.
    3. 3Graduate Program in Pharmaceutical Sciences, Institute of Health Sciences, Federal University of Pará; Pharmaceutical Innovation Graduate Program, Institute of Health Sciences, Federal University of Pará, Belém, Pará, BRAZIL.

    CORRESPONDENCE

    Marcieni Ataíde Andrade

    Graduate Program in Pharmaceutical Sciences, Institute of Health Sciences, Federal University of Pará, Belém, Pará, BRAZIL.

    marcieni@ufpa.br

    Volume 9, Issue 1 · pp. 96–100 · PUBLISHED · DOI: 10.4103/0974-8490.199772

    View on Pharmacogn. Res. original site ↗

    ABSTRACT

    Background:Chrysobalanus icaco is a medicinal plant commonly used to treat fungal infections in Brazilian Amazonian region. Objective:This work aimed to evaluate the antifungal activity of the hydroalcoholic extract of C. icaco (HECi) against oral clinical isolates of Candida spp. and to determine the pharmacognostic parameters of the herbal drug and the phytochemical characteristics of HECi. Materials and Methods: The pharmacognostic characterization was performed using pharmacopoeial techniques. Phytochemical screening, total flavonoid content, and high-performance liquid chromatography (HPLC) analysis were used to investigate the chemical composition of the HECi. A broth microdilution method was used to determine the antifungal activity of the extract against 11 oral clinical isolates of Candida spp.Results: Herbal drug presented parameters which were within the limits set forth in current Brazilian legislation. A high amount of flavonoid content (132,959.33 ± 12,598.23 μg quercetin equivalent/g of extract) was found in HECi. Flavonoids such as myricetin and rutin were detected in the extract by HPLC analyses. HECi showed antifungal activity against oral isolates of Candida albicans and Candida parapsilosis(minimum inhibitory concentrations [MIC] 3.12 and 6.25 mg/mL, respectively), andC. albicansAmerican American Type Culture Collection (MIC <1.56 mg/mL). Conclusion: HECi was shown to possess antifungal activity against Candidaspecies with clinical importance in the development of oral candidiasis, and these activities may be related to its chemical composition. The antifungal activity detected for C. icaco against Candidaspecies with clinical importance in the development of oral candidiasis can be attributed to the presence of flavonoids in HECi, characterized by chromatographic and spectroscopic techniques.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Silva, J. P. B., Peres, A. R. M. N., Paixão, T. P., Silva, A. S. B., Baetas, A. C., Barbosa, W. L. R., Monteiro, M. C., & Andrade, M. A. (). Antifungal Activity of Hydroalcoholic Extract of Chrysobalanus icaco Against Oral Clinical Isolates of Candida Species. Pharmacognosy Research, 9(1), 96–100. https://doi.org/10.4103/0974-8490.199772